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ABSTRACT The ability to de novo synthesize purines has been associated with the
intracellular survival of multiple bacterial pathogens. Uropathogenic Escherichia coli
(UPEC), the predominant cause of urinary tract infections, undergoes a transient in-
tracellular lifestyle during which bacteria clonally expand into multicellular bacterial
communities within the cytoplasm of bladder epithelial cells. Here, we characterized
the contribution of the conserved de novo purine biosynthesis-associated locus
cvpA-purF to UPEC pathogenesis. Deletion of cvpA-purF, or of purF alone, abolished
de novo purine biosynthesis but did not impact bacterial adherence properties in
vitro or in the bladder lumen. However, upon internalization by bladder epithelial
cells, UPEC deﬁcient in de novo purine biosynthesis was unable to expand into intra-
cytoplasmic bacterial communities over time, unless it was extrachromosomally com-
plemented. These ﬁndings indicate that UPEC is deprived of purine nucleotides
within the intracellular niche and relies on de novo purine synthesis to meet this
metabolic requirement.
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Numerous bacterial pathogens gain entry into nonphagocytic host cells, where theyreside unperturbed by host defenses and antibiotic intervention. Upon uptake,
intracellular pathogens such as Salmonella and Yersinia occupy and replicate within
membrane-bound vacuoles, while other invasive bacteria, including Shigella, Listeria,
and Burkholderia, are able to escape from endocytic vacuoles to reside within the host
cell cytoplasm (1). The precise intracellular localization of internalized bacteria relies on
the expression of speciﬁc virulence factors, as well as the ability of the bacteria to
acquire essential nutrients from the host (1). Because intracellular bacterial metabolism
relies on either the uptake of resources for de novo synthesis or the direct exploitation
of host metabolites, deﬁning the nutritional requirements for intracellular bacterial
replication can provide valuable insight into the establishment and progression of
infection.
Uropathogenic Escherichia coli (UPEC), the predominant cause of urinary tract
infections (UTIs) (2, 3), has a transient intracellular lifestyle within terminally differen-
tiated superﬁcial bladder epithelial cells during the acute phase of infection (4, 5). This
intracellular stage begins with UPEC attachment to mannosylated receptors on the
urothelium, primarily via adhesive ﬁbers called type 1 pili (6, 7). Binding, as well as
stochastic internalization during contraction of the bladder during voiding (8), leads to
bacterial internalization. The majority of internalized UPEC is nonlytically regurgitated
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into the bladder lumen via a Toll-like receptor 4 (TLR4)-dependent mechanism (9, 10).
However, if a bacterium escapes expulsion, it clonally expands within the host cell
cytosol, forming a bioﬁlm-like multicellular structure comprising 104 to 105 tightly
packed UPEC cells (4, 5). These structures, termed intracellular bacterial communities
(IBCs), are held together by type 1 pili (11) and exhibit differential gene expression
reminiscent of that of bioﬁlms (12). Similar to bioﬁlms, bacteria within IBCs are
protected from host cell insults and can disperse to secondary sites, facilitating disease
propagation and adverse disease outcomes such as recurrence and chronic symptom-
atic colonization (12–14).
Few investigations have probed UPEC nutritional requirements during acute UTI.
Previous studies have demonstrated a requirement for amino acid utilization during
acute UTI and have indicated that UPEC, despite being a facultative anaerobe, requires
aerobic respiration to establish infection (15–18). Transcriptional studies investigating
the proﬁles of UPEC during acute infection also revealed increased expression of
siderophores, indicative of iron limitation and/or electron scavenging for aerobic
respiration, as well as utilization of alternative carbon sources (15, 19, 20). However,
these studies did not capture requirements for nucleotide metabolism pathways.
One limitation to the identiﬁcation of UPEC factors that are critical for intracellular
survival is the UPEC pathogenic cascade itself, which comprises several bottlenecks that
preclude the use of large-scale in vivo screens. In murine models of acute UTI, 10 million
bacteria are instilled via transurethral catheterization to the bladder lumen, and of
these, the vast majority are eliminated by micturition (12). Of approximately 1,000
bacteria that adhere to the bladder epithelial cells, only about 100 will become IBC
progenitors (12). To partially surpass these limitations, a transposon mutagenesis
analysis identiﬁed several IBC effectors through the screening of UPEC mutants defec-
tive for in vitro bioﬁlm formation under multiple growth and nutrient conditions (21).
Among the factors identiﬁed as modulators of bioﬁlm formation was the inner mem-
brane protein colicin V production accessory protein (CvpA) (21). This ﬁnding was
intriguing because loss of CvpA impacted bioﬁlm formation without impairing produc-
tion of type 1 pili, which are considered to be the paramount adhesive ﬁber during
bioﬁlm formation in vivo (21). In UPEC, cvpA is localized within an operon upstream of
the purine biosynthesis-associated gene purF (22). PurF catalyzes the ﬁrst committed
step in the de novo purine biosynthesis pathway, which is essential for cellular repli-
cation under conditions in which bacteria are unable to scavenge for exogenous
nucleotides. Disruption of de novo purine biosynthesis has been shown to attenuate
the virulence of several intracellular pathogens, including Salmonella, Burkholderia,
Brucella, and Francisella (23–26). Thus far, the role of de novo purine synthesis in UPEC
pathogenesis has not been elucidated.
Here, we investigated the function of CvpA and PurF in UPEC pathogenesis. We
report that de novo purine biosynthesis is critical for bacterial proliferation within the
bladder epithelial cell cytosol and demonstrate preliminary evidence that CvpA may
play a contributing role in the bacterial defense against neutrophil-mediated killing.
RESULTS
Production of PurF depends on the presence of cvpA. A previous transposon
mutant library screen generated in the cystitis isolate UTI89 identiﬁed several deter-
minants required for in vitro bioﬁlm formation, including cvpA (21). Unmarked, clean
deletion of cvpA recapitulated in vitro bioﬁlm phenotypes of the Tn::cvpA mutant,
further demonstrating a role of cvpA in bioﬁlm development (21). Previous work had
mapped the transcriptional start site of the purF gene, encoding the corresponding de
novo purine biosynthesis enzyme PurF, to a region upstream of the operon containing
cvpA (22, 27). However, real-time quantitative PCR (qPCR) analysis of statically grown
UTI89 cultures revealed that in comparison to wild-type (WT) UTI89, the unmarked
ΔcvpAmutant produced levels of purF transcript that were decreased by approximately
15-fold (Fig. 1A), despite genetic maintenance of the previously mapped cvpA-purF
transcriptional start site (22, 27). Further scrutiny of the literature revealed that purF
Shaffer et al. Infection and Immunity
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expression was linked to the production of cvpA (22, 27). Given that the sequences
encoding cvpA-purF are nearly identical in UTI89 and the previously reported strains, we
hypothesized that the cvpA deletion impaired expression of purF. Indeed, steady-state
levels of purF transcript were approximately 40-fold greater when ΔcvpA was comple-
mented with a plasmid harboring the cvpA-purF operon under the control of the
endogenous promoter (ΔcvpA/pcvpA-purF) than for the WT (Fig. 1A).
PurF catalyzes the addition of an amino group derived from glutamine to the C-1
position of phosphoribosyl pyrophosphate (PRPP) in the ﬁrst committed step of de novo
purine biosynthesis (28) (Fig. 1B). To evaluate de novo purine biosynthesis in vitro, we
evaluated the ability of the ΔcvpA mutant to replicate in M9 minimal medium, which
is devoid of exogenous purines. As expected, the ΔcvpAmutant was unable to replicate
FIG 1 UPEC cvpA-purF is required for purine biosynthesis and bioﬁlm formation. (A) qPCR evaluating steady-state transcript levels of purF in statically grown
UTI89 cultures. The graph depicts relative the fold change of the purF transcript normalized to levels of gyrB and compared to WT UTI89. (B) Schematic
representation of the de novo purine biosynthesis pathway in E. coli (adapted from KEGG pathway analysis). PRPP, phosphoribosyl pyrophosphate. (C) Growth
of UTI89 mutants in M9 minimal medium. (D) Metabolic complementation of UTI89 isogenic mutants deﬁcient in de novo purine biosynthesis. (E) Growth of
purine biosynthesis mutants in human urine. In panels C to E, graphs depict the average CFU per milliliter of bacterial culture at the indicated time points, and
data represent the mean  standard error of the mean (SEM) for at least three independent experiments. (F) UPEC bioﬁlm formation in YESCA-PVC. The graph
depicts the percent bioﬁlm production by each strain compared to the WT UTI89 OD565 reading, which represents 100%. Bars represent the mean bioﬁlm
production  SEM for at least three independent experiments. The P values in panel F were calculated by one-way ANOVA with Dunnett’s post hoc correction
for multiple comparisons to WT values. ****, P  0.0001.
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in the absence of exogenous purines (Fig. 1C). Bacterial replication in M9 medium was
restored to WT levels in the ΔcvpA/pcvpA-purF strain (Fig. 1C). The replication defects of
a ΔpurF clean deletion mutant mirrored those of the ΔcvpA mutant, and likewise, ΔpurF
could be rescued by complementation with pcvpA-purF (ΔpurF/pcvpA-purF) (Fig. 1C).
IMP is the product of the purine metabolism enzyme purH (Fig. 1B), and it represents
a branch point of the purine biosynthetic pathway that can be converted into either
AMP or GMP (Fig. 1B). Both the ΔcvpA and ΔpurF mutants were able to reach ﬁnal cell
densities close to that of the WT in M9 medium supplemented with IMP, reaching 109
CFU/ml of culture (Fig. 1D) and demonstrating that these mutants can sufﬁciently take
up exogenous metabolites required to complete the ﬁnal steps of de novo purine
biosynthesis. As a control, a UTI89 ΔpurH mutant, which was also previously reported
to exhibit bioﬁlm formation defects (21), could be metabolically complemented by the
addition of IMP to minimal medium (Fig. 1D). Collectively, these data established that
cvpA mutants are purine auxotrophs due to ablation of purF expression in the ΔcvpA
background. Furthermore, both the ΔpurF and ΔcvpA mutants proliferated in human
urine (Fig. 1E), suggesting that the purine content within the urine can sustain growth
of UTI89 ΔcvpA-purF and isogenic derivatives and implying that the bladder lumen
could serve as a replicative niche for these isogenic mutants.
Purine biosynthetic pathways are required for UPEC bioﬁlm formation in vitro.
Given that a previous study identiﬁed cvpA and purH as UPEC bioﬁlm effectors under
in vitro conditions (21) we next sought to analyze the effects of the purF deletion on in
vitro bioﬁlm production. Both Tn::cvpA and Tn::purH mutants were previously shown to
have altered production of curli adhesive ﬁbers (21). Consistent with previous studies,
UTI89 ΔcvpA was unable to form bioﬁlms under conditions with yeast extract-Casamino
Acids (YESCA) medium and polyvinyl chloride (PVC) (Fig. 1F), which promote a bioﬁlm
that depends primarily on the expression of curli and cellulose (29). Notably, UTI89
ΔcvpA exhibits a moderate growth defect during growth in YESCA medium (21). The
growth and bioﬁlm defects in this medium could be rescued by cvpA-purF genetic
complementation (Fig. 1F). Similarly, the ΔpurF mutant was unable to form bioﬁlms in
YESCA medium, and this phenotype was rescued by extrachromosomal expression of
cvpA-purF (Fig. 1F). In order to evaluate the speciﬁc contribution of CvpA in bioﬁlm
formation, we introduced a stop codon within the cvpA coding region of the pcvpA-
purF plasmid [pcvpA(STOP)-purF] and introduced this plasmid into the ΔpurF strain
[ΔpurF/pcvpA(STOP)-purF]. Under the tested conditions, the ΔpurF/pcvpA(STOP)-purF strain
formed bioﬁlms at WT levels, thus demonstrating that CvpA is dispensable during in
vitro bioﬁlm formation (Fig. 1F) and that de novo purine biosynthesis is required for
bioﬁlm formation during growth in YESCA medium. Mutants deﬁcient in purine bio-
synthetic pathways exhibited WT motility levels (see Fig. S1 in the supplemental
material), indicating that the observed bioﬁlm defects are not due to an alteration in
the production of ﬂagella. In total, these data indicate that disruption of cvpA imparts
a polar mutation that signiﬁcantly decreases de novo purine biosynthesis and that
endogenous purine synthesis, but not CvpA production, is required for UTI89 bioﬁlm
formation in vitro. Because our studies demonstrate that clean deletion of the cvpA
gene impairs purF transcription, below we denote UTI89 ΔcvpA as UTI89 ΔcvpA-purF.
Purine biosynthesis mutants elaborate type 1 pili and adhere to immortalized
bladder epithelial cells in vitro. UPEC adherence is the ﬁrst step leading to infection
within the urinary tract. If a mutation impairs adherence, the IBC cascade is confounded
during infection (11). We therefore sought to investigate the impact of impaired purine
biosynthesis on UPEC interactions with human bladder epithelial cells (BECs). Previous
studies have demonstrated that type 1-piliated UPEC can adhere to and become
internalized within cultured BECs, including the 5637 bladder carcinoma cell line (6, 13).
Adherence assays revealed that loss of purF alone, or loss of both cvpA and purF, did
not alter the ability of UPEC to adhere to BECs (Fig. 2A). Immunoblot analyses probing
for the primary pilin subunit FimA indicated that all strains tested in adherence and
internalization studies produced FimA levels that were similar to those produced by WT
Shaffer et al. Infection and Immunity
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UTI89 (Fig. 2A, inset). Interestingly, the adherence levels of the ΔpurF/pcvpA-purF strain
exceeded those of WT UTI89, suggesting that excess cvpA-purF expression augments
bacterial adherence. To understand the basis of enhanced bacterial adherence ob-
served in the ΔpurF/pcvpA-purF strain, we assayed the extent of piliation in the
ΔpurF/pcvpA-purF strain, using an indirect approach. UPEC elaborating type 1 pili can
FIG 2 Purine biosynthesis modulates bacterial adherence and entry into bladder epithelial cells. 5637
bladder epithelial cells (BECs) were cultured with the indicated UPEC strain. (A) Quantiﬁcation of total
adherent (cell-associated) and intracellular UPEC bacteria. The graph depicts the geometric mean (bars)
and 95% conﬁdence interval (whiskers) of bacterial titers recovered from BEC monolayers expressed as
a percentage of total UPEC bacteria recovered from control wells for at least ﬁve independent experi-
ments. Inset, immunoblot depicting production of the type 1 pilus major subunit FimA by each UTI89
strain (-FimA). (B) Hemagglutination (HA) of guinea pig erythrocytes, measuring assembly of type 1 pili
adhesive ﬁbers by the indicated UTI89 strain in the presence or absence of mannose. PBS, phosphate-
buffered saline. The graph depicts the average HA titer of guinea pig red blood cells by mannose-
sensitive type 1 pili obtained in two independent experiments. (C) Percentage of UTI89 strains internal-
ized by BECs by 2 h postinfection. The graph depicts the geometric mean (bars) and 95% conﬁdence
interval (whiskers) of internalized bacterial titers expressed as a percentage of total CFU recovered from
control wells from at least ﬁve biological replicate experiments. (D) BEC expulsion of internalized UPEC
was assayed at 4 h after gentamicin treatment. Data are expressed as the geometric mean (bars) and 95%
conﬁdence interval (whiskers) of the percentage of total internalized UPEC expelled into cell culture
supernatants following gentamicin treatment. In panels A and C, P values were calculated by one-way
ANOVA with Dunnett’s post hoc correction for multiple comparisons to WT values. ***, P  0.001; **, P 
0.01. The P values in panel D were calculated by two-tailed t test.
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agglutinate guinea pig red blood cells in a type 1 pilus-dependent manner via inter-
actions of the tip adhesin FimH with mannosylated receptors on the erythrocyte surface
(30); thus, the addition of mannose in hemagglutination (HA) reactions can sequester
FimH-producing bacteria to unmask the production of additional ﬁbers that may
agglutinate erythrocytes (30). In our hemagglutination assays, all strains exhibited
similar mannose-sensitive HA titers (Fig. 2B), suggesting that differential expression of
type 1 pili or production of other appendages that can agglutinate guinea pig red
blood cells is not a contributing factor to the increased BEC binding exhibited by the
ΔpurF/pcvpA-purF strain.
UPEC purine auxotrophs exhibit altered rates of bacterial expulsion from
immortalized human BECs. The adherence assays demonstrated that purine biosyn-
thesis mutants have no defect in the production of type 1 pili, which are critical for
UPEC adhesion to the bladder epithelial surface. Using gentamicin protection assays,
we next analyzed the number of internalized bacteria for each strain. In these assays,
the ΔpurF and ΔpurF/pcvpA-purF mutants were internalized at levels that were not
statistically signiﬁcantly different than those of WT UTI89 (Fig. 2C). Notably, the ΔcvpA-
purF strain was consistently internalized at signiﬁcantly higher levels than WT UTI89
(Fig. 2C); genetic complementation of ΔcvpA-purF restored bacterial internalization
titers to WT levels (Fig. 2C). The basis of the observed increased internalization into
human bladder epithelial cells remains unknown.
When UPEC enters BECs, a TLR4-mediated defense mechanism that leads to nonlytic
expulsion of UPEC is triggered (9). UPEC cells that are expelled from BECs can further
be encased within host membrane-derived vesicles that contain caveolin-1 and Rab27b
(9, 10). We therefore investigated whether loss of cvpA-purF alters the dynamics of
bacterial expulsion by BECs. BEC monolayers were infected with either the WT or
ΔcvpA-purF strain for 1 h, followed by gentamicin treatment to eliminate extracellular
bacteria. At this point, gentamicin-protected monolayers in replicate wells were lysed,
and initial intracellular titers were determined for each strain (corresponding to time
zero). To the remaining wells, bacteriostatic sulfamethoxazole and D-mannose were
added to prevent bacterial replication and ﬁm-mediated reattachment and entry,
respectively. Following 4 h of incubation, we determined the number of extracellular
UPEC bacteria by enumeration of CFU expelled into the cell culture supernatants. This
time point was previously shown to correspond with peak UPEC expulsion from BECs
(10). At 4 h after gentamicin treatment, we found that compared to the WT, fewer
ΔcvpA-purF bacteria were present in the cell culture supernatant (Fig. 2D). These data
suggest that there is reduced expulsion of ΔcvpA-purF bacteria into the cell culture
medium, which is potentially due to less efﬁcient recognition by the innate immune
response.
Purine biosynthesis promotes UPEC colonization of the bladder. We next
sought to analyze the contribution of de novo purine synthesis in bacterial colonization
and intracellular expansion in a murine model of acute UTI. Female 7- to 8-week-old
C3H/HeN mice were transurethrally inoculated with the WT, ΔcvpA-purF, or ΔcvpA-purF/
pcvpA-purF strain as previously described (31), and bladder bacterial burdens were
recorded at 3, 6, and 16 h postinfection, marking the acute stages of the UPEC
pathogenic cascade (5). In comparison to WT UTI89, the ΔcvpA-purF (Fig. 3A) and ΔpurF
(Fig. 3C) mutants were signiﬁcantly impaired in their ability to colonize the bladder, and
this defect was rescued by extrachromosomal genetic complementation.
In the murine model of UTI employed in our studies, UPEC adheres to BECs and
becomes internalized within 3 h postinfection, with vacuolar escape and expansion into
IBCs occurring by 6 h postinfection. While the in vitro studies preceding the mouse
infections suggested that expression of type 1 pili (which is critical for UPEC adherence
[7] and IBC cohesion [11]) was unaltered in the ΔcvpA-purF strain, it is possible that this
mutant displays a piliation defect in vivo. To evaluate this possibility, we generated a
ΔcvpA-purF deletion in UTI89 ﬁmLON, a previously constructed strain in which the
phase-variable ﬁm promoter element (32) is genetically locked into the transcriptionally
Shaffer et al. Infection and Immunity
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competent state (33). Subsequent analyses of the ﬁtness of the resulting strain in vivo
revealed that compared to those of WT UTI89, the UTI89 ΔcvpA-purF ﬁmLON bladder
titers remained signiﬁcantly reduced (Fig. 3A), suggesting that reduced bladder colo-
nization by purine biosynthesis mutants is not due to defects in differential transcrip-
tion of the ﬁm operon in vitro and in vivo.
We next determined the intracellular population of each UPEC strain during the
early stages of UTI. Using gentamicin treatment to eliminate extracellular bacteria from
the excised bladder, we observed that at 3 h postinfection, the intracellular numbers of
all UPEC strains lacking cvpA-purF were slightly lower (but not statistically signiﬁcantly
different) than the intracellular numbers obtained for WT UTI89 (Fig. 3B). By 6 h
postinfection, the intracellular titers of the ΔcvpA-purF (Fig. 3B), ΔcvpA-purF ﬁmLON (Fig.
3B), and ΔpurF (Fig. 3D) strains were dramatically reduced compared to those of either
WT or the corresponding complemented strains, indicating that de novo purine bio-
synthesis plays a critical role in UPEC expansion in the intracellular compartment.
Purine biosynthesis mutants exhibit a minor defect in vacuolar escape. One
critical step of the UPEC pathogenic cascade that remains poorly characterized is the
mechanism by which bacteria exit the endocytic vacuole. Previous studies have em-
ployed chloroquine resistance assays to discriminate vacuolar versus cytosolic Gram-
negative bacteria (34, 35). Aiming to better understand the defect observed in the
murine studies described above, we adapted the chloroquine resistance assay and
evaluated its potential use as a tool to discriminate between internalized vacuolar and
cytoplasmic UPEC subpopulations. In initial, proof-of-principle studies, we combined
gentamicin and chloroquine resistance assays to determine the proportion of UPEC
bacteria that enter the cytoplasm of cultured human BECs. Treatment of UPEC-infected
FIG 3 UTI89 purine auxotrophs are attenuated in a murine model of acute urinary tract infection. (A) Bladder bacterial titers
recovered from C3H/HeN mice infected with the indicated UTI89 strain at 3, 6, and 16 h postinfection. (B) Intracellular
bacterial titers recovered from whole gentamicin-treated bladders infected with UTI89 cvpA-purF mutants at the indicated
time points of infection. (C) Bladder bacterial titers obtained from C3H/HeN mice infected with the indicated purF mutant.
(D) Intracellular bacterial titers recovered from whole gentamicin-treated bladders infected with the indicated purF mutant
at 3 and 6 h postinfection. The lines in all panels represent the geometric mean of the distribution, and each circle
represents bacterial CFU recovered from one individual mouse bladder. P values were calculated by the two-tailed
Mann-Whitney t test. ****, P  0.0001; ***, P  0.001; **, P  0.01; *, P  0.05.
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BECs with gentamicin in combination with chloroquine revealed distinct subpopula-
tions of bacteria within BECs that presumably localize to the BEC cytoplasm (see Fig.
S2A in the supplemental material). At high concentrations (2.5 mg/ml [34]), chloroquine
treatment only slightly reduced the viability of planktonic UPEC in batch culture (Fig.
S2B), while chloroquine treatment of intracellular UPEC in cultured BECs reduced the
recoverable bacterial titers by 20- to 100-fold (Fig. S2A). Consistent with previous
reports, these studies indicate that chloroquine reaches an active threshold concen-
tration within host cell vacuoles that is sufﬁcient to perturb the viability of vacuole-
bound intracellular UPEC. Thus, a gentamicin and chloroquine resistance assay allows
for the compartmental discrimination of UPEC due to concentration of lysosomotropic
chloroquine in UPEC-containing vacuoles to levels that reduce the viability of intra-
vacuolar bacteria (35), while the concentration of chloroquine within the host cell
cytoplasm remains insufﬁcient to signiﬁcantly perturb bacterial viability (34, 36). In
cultured BECs, we observed signiﬁcantly decreased resistance of the ΔcvpA-purF strain
to chloroquine treatment compared to that of either the WT or ΔcvpA-purF/pcvpA-purF
strain (Fig. S2A). These data suggest that fewer ΔcvpA-purF bacteria are localized to the
host cell cytosol in the cultured BECs at the tested time point, suggesting that in this
in vitro assay, purine biosynthesis mutants may exhibit delayed or impaired egress from
host cell vacuoles.
We next investigated the intravacuolar and cytoplasmic subpopulations of internal-
ized UPEC in the murine bladder. For these studies, we used gentamicin treatment to
determine the overall intracellular bacterial titers at 3 h (Fig. 3B) and 4 h (Fig. 4A)
postinfection. At both time points, the ΔcvpA-purF mutant exhibited reduced intracel-
lular titers, although the reduction of recoverable titers at 3 h was not statistically
different from that for the WT (Fig. 3B). By 4 h postinfection, a time point at which
FIG 4 De novo purine biosynthesis is required for bacterial expansion in the urothelial cell cytoplasm. (A) Chloroquine and gentamicin
protection assays were utilized to enumerate bacterial titers recovered from C3H/HeN bladder compartments at 4 h postinfection. (B)
Total bacterial titers recovered from C3H/HeJ whole bladders infected for 3, 4, or 6 h with the indicated UTI89 strain. (C) Gentamicin
and chloroquine resistance assays were utilized to enumerate the bacterial CFU contained within each C3H/HeJ bladder cell partition
at 3 h postinfection (early acute infection). (D) Bacterial titers recovered from gentamicin- and chloroquine-treated C3H/HeJ bladders
at 4 h postinfection (bacterial cytoplasmic expansion and early IBC formation). Lines represent the geometric mean of each
distribution, and each circle represents bacterial titers recovered from one individual mouse. P values were calculated by the
Mann-Whitney t test. ****, P  0.0001; ***, P  0.001; **, P  0.01; *, P  0.05.
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escape from the vacuole has occurred and IBC expansion is under way (5), we observed
a statistically signiﬁcant reduction in total intracellular ΔcvpA-purF titers compared to
those of either WT or ΔcvpA-purF/pcvpA-purF strain (Fig. 4A). However, chloroquine
resistance assays utilized to determine the number of bacteria localized to the host cell
cytosol revealed that the ΔcvpA-purF titers did not signiﬁcantly differ from those
recovered for total intracellular ΔcvpA-purF bacteria (Fig. 4A). These data suggest that
in contrast to the case in cultured human BECs, the majority of intracellular purine
biosynthesis mutants are localized to the host cell cytoplasm by 4 h postinfection and
do not exhibit an apparent defect in exiting the endocytic vacuole.
We next analyzed the ability of purine biosynthesis mutants to colonize C3H/HeJ
mice, which fail to respond to lipopolysaccharide (LPS) due to a point mutation within
the tlr4 locus (37). These experiments were aimed at examining whether TLR4 activa-
tion contributes to reduced cytosolic proliferation of the ΔcvpA-purF mutant. Transure-
thral inoculations followed by CFU analyses indicated that compared to the WT,
ΔcvpA-purF bladder titers were decreased in C3H/HeJ mice by 4 h postinfection (Fig.
4B), and remained consistently low at 6 h postinfection, similar to bacterial colonization
observed in C3H/HeN mice. Similarly, at 3 h postinfection, luminal and total intracellular
ΔcvpA-purF titers were markedly reduced compared to those of either the WT or
ΔcvpA-purF/pcvpA-purF strain (Fig. 4C). Bacterial subcellular localization studies using
gentamicin and chloroquine resistance assays indicated a modest (3.5-fold) reduction in
the recovery of cytosolic ΔcvpA-purF CFU in chloroquine-treated bladders compared to
total intracellular bacteria at 4 h postinfection in this mouse background (Fig. 4D).
Conversely, the number of WT and ΔcvpA-purF/pcvpA-purF bacteria localized to the
host cell cytoplasm did not differ from total intracellular titers (Fig. 4D). These obser-
vations suggested that in C3H/HeJ mice, UTI89 ΔcvpA-purF may exhibit a defect or a
delay in vacuolar escape. Taken together, these data suggest that de novo purine
biosynthesis is required for bacterial replication and expansion within the bladder
epithelial cell cytosol.
DISCUSSION
The capacity of the vertebrate host to deprive intracellular bacteria of essential
nutrients and metabolites is a powerful innate immune defense mechanism. Within the
host, a transient intracellular lifestyle enables UPEC to remain shielded from antibiotic
intervention and subvert host surveillance mechanisms that are recruited to the site of
infection. Here, we show that UPEC requires de novo purine biosynthesis to expand
within the cytoplasm of superﬁcial bladder facet cells during acute UTI. In order to
establish acute UTI and progress to later stages of infection, UPEC must overcome
several critical bottlenecks, including avoidance of the host immune response, entry
into the superﬁcial bladder epithelium, and escape from the endocytic vacuole in which
the bacterium is encased. The mechanism and factors driving UPEC escape from the
vacuole are unknown. While other intracellular pathogens deploy needle-like append-
ages associated with type III or type IV secretion systems to manipulate the host cell
and facilitate intravacuolar survival and/or escape (1), these systems are rarely harbored
by uropathogenic E. coli. Although several toxins have been described as UPEC viru-
lence factors, including hemolysin A (38), none of these factors are essential for UPEC
manipulation of the host vacuolar space or for UPEC escape into the host cell cytosol.
One previous study exploring the metabolic requirements of UPEC growth during UTI
identiﬁed guanine biosynthesis as essential for growth in human urine and virulence
during experimental murine infection (39), and another study discovered that loss of
pyrimidine nucleotide synthesis led to attenuation of UPEC survival within the urinary
tract (40). In contrast, our data demonstrate that UTI89 mutants lacking intact purine
biosynthetic pathways can replicate in human urine (Fig. 1E).
Disruption of bacterial purine biosynthesis pathways has been shown to play a role
in the niche colonization and intracellular lifestyle of other pathogens, including
Burkholderia pseudomallei (26), Brucella abortus (25), Salmonella enterica serovar Typhi-
murium (24, 41), Campylobacter jejuni (42), Francisella tularensis (23, 43), and Listeria
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monocytogenes (44). Although these pathogens harbor cvpA and purF orthologs, ge-
netic colocalization of the cvpA-purF loci is not universally maintained. Interestingly, the
cvpA-purF operon is conserved among UPEC strains, as well as strains of other uro-
pathogens, including Klebsiella pneumoniae and Proteus mirabilis. We speculate that
maintenance of cvpA-purF genetic synteny in UPEC isolates may reﬂect a specialized
role of cvpA during colonization of the urinary tract. In addition, these studies surmise
that the host cell cytosol contains limiting amounts of essential purine metabolites that
are available for import into intracellular bacteria; thus, de novo purine biosynthesis is
crucial for bacterial replication within this nutrient-starved environment. The lack of
purine nucleotides within the host cell cytoplasm may therefore serve as a metabolic
cue that can be sensed by UPEC to signal that the bacterium has reached the cytosol.
Our studies indicated that in a TLR4-competent mouse strain, vacuolar escape is not
impeded by the lack of an intact purine biosynthetic pathway. Future studies will
interrogate mechanisms that facilitate UPEC escape from the vacuole. Recent transcrip-
tome sequencing (RNA-seq) analyses investigating the UPEC transcriptome during the
middle stage of IBC formation (6 h postinfection) identiﬁed highly activated alternative
carbon source pathways but did not pinpoint upregulation of de novo purine synthesis
(19). Consistent with these studies, sampling of bacterial mRNA isolated from the acute
stages of infection did not identify upregulation of cvpA-purF during infection, sug-
gesting a posttranscriptional mode of regulation (data not shown).
Previous work has suggested that defective purine metabolism can render bacteria
more susceptible to the oxidative burst, presumably because of an inability to repair
damage cause by reactive oxygen species (24). CvpA was previously shown to be
essential for the production of colicin V (22), a small peptide antibiotic (a “bacteriocin”)
that kills E. coli cells by inserting into the inner membrane and disrupting membrane
potential (45). E. coli produces many different types of bacteriocins with diverse killing
mechanisms, and the genes encoding each bacteriocin are typically coexpressed with
cognate transport systems (46). In UPEC strains, studies demonstrated that bacteriocins
and other pore-forming toxins such as -hemolysin (HlyA) are upregulated during
infection and contribute to pathogenesis (38, 47). For example, HlyA is capable of
suppressing the host inﬂammatory response through disruption of NF-B signaling,
degradation of the cytoskeletal scaffolding protein paxillin, and attenuation of macro-
phage chemotaxis (38, 47). However, the involvement of CvpA in these toxin-mediated
processes remains unexplored. While CvpA is conserved among E. coli strains, the
repertoire of bacteriocins and hemolysins harbored by each strain varies depending on
plasmid content and the type and number of pathogenicity islands present in the
chromosome of each isolate. It is thus possible that CvpA is critical for the secretion of
several different bacteriocins or toxins or that it has an additional function that warrants
genetic conservation across strains. In future studies, we will aim to characterize the
contribution of CvpA to the secretion of UPEC toxin repertoires. Preliminary studies
probing the effects of CvpA on UPEC survival against polymorphonuclear leukocytes
(PMNs) suggest a modest defect of a strain lacking CvpA (see Fig. S3 in the supple-
mental material). In summary, this work demonstrates that the cvpA-purF locus is
required for optimal UPEC intracellular replication and expansion into IBCs during acute
UTI in murine infection models. We demonstrate that de novo purine synthesis is
required after UPEC internalization into bladder epithelial cells, suggesting that the
urothelial cell cytosol restricts purine availability and, in turn, constrains bacterial
survival within the intracellular niche.
MATERIALS AND METHODS
Bacterial strains and constructs. UTI89 (and derivatives thereof) is a UPEC cystitis isolate (13) used
in all of the studies described here. UTI89 ﬁmLON is a previously constructed isogenic strain in which the
left invertible repeat that serves as a recognition site for ﬁm promoter recombination and inversion has
been mutated (preventing the ON¡OFF inversion) (33). UTI89 nonpolar isogenic gene deletions were
constructed using the  Red recombinase system following the method of Murphy and Campellone (48).
UTI89 ΔcvpA and UTI89 ΔpurH were previously generated and characterized (21). A UTI89 ΔpurF
isogenic mutant was generated using the  Red recombinase system and primers purF-KO_Left
(5=-TCATCCTTCGTTATGCATTTCGAGATTTTCCACTTCGTTCTGACGTTGCAGTGTAGGCTGGAGCTGC
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TTC-3=) and purF-KO_Right (5=-CGATGATCATCGGCCACGGTATGGTTGCTTTCCGCGATCCTAACGGGATT
CTATGAATATCCTCCTTAG-3=). Deletion of purF was conﬁrmed using test primers Test_KOpurF R
(5=-CACTACCCGCTGGAAGCC-3=) and Test_KOpurF_L (5=-GCCCTGTCAGACTTGCAGG-3=). UTI89 ΔcvpA
and UTI89 ΔpurF were complemented by transformation via electroporation with pTRC99A containing the
cvpA-purF locus under the control of the native promoter upstream of cvpA (22, 27). The resulting comple-
mentation construct, pcvpA-purF, was generated by amplifying cvpA-purF from UTI89 using primers
cvpA_purF_pTRC99AF (5=-CGGAATTCTCATCCTTCGTTATGCATTTCGAG-3=) and cvpA_purF_pTRC99AR (5=-CGA
AGCTTCCAGCGCGTCTTATCAGGCCTGTGCTGG-3=) and cloning of the amplicon into pTRC99A by BamHI/
HindIII restriction digestion (NEB) and ligation by T4 DNA ligase (Promega). Site-directed mutagenesis
using primers cvpA_stop_F (5=-GGCCAGTTGGTGGAGTAAACGGGGTTGTCAGGCACC-3=) and cvpA_stop_R
(5=-GGTGCCTGACAACCCCGTTTACTCCACCAACTGGCC-3=) was used to insert the stop codon TAA within
the cvpA coding region [pcvpA(STOP)-purF] using pcvpA-purF as a template. UTI89 strains harboring either
empty pTC99A (vector-only controls) or cvpA-purF constructs were maintained in lysogeny broth (LB)
supplemented with 100 g/ml ampicillin.
Growth curves. All overnight cultures described in this work were seeded in LB and incubated at
37°C with shaking. For growth curves, overnight cultures were used to seed either M9 minimal medium
(1 M9 salts, 2 mM MgSO4, 0.1 mM CaCl2, 0.4% glucose, 50 g/ml niacin) or M9 medium supplemented
with 40 mM IMP (Sigma) at an optical density at 600 nm (OD600) of 0.1. Cultures were incubated with
shaking at 37°C, and aliquots were taken at 60-min intervals for OD600 measurements and CFU
enumeration by serial dilution plating. Analysis of UPEC growth in human urine was performed on
pooled, ﬁltered, sterilized urine, which was collected under the Vanderbilt Institutional Review Board
(IRB) protocol (151465) and ﬁltered through a 0.22-m-pore-size ﬁlter before use.
In vitro bioﬁlm assays. UTI89 strains grown overnight in LB as described above were diluted 1:1,000
in fresh LB and grown to an OD600 of 1. Strains were subcultured (1:500) in yeast extract-Casamino Acids
(YESCA) medium and used to seed 96-well PVC plates. Bioﬁlm formation was quantiﬁed after a 48-h static
incubation at room temperature (ranging from 23 to 24°C), using the colorimetric crystal violet method
as previously described (21). Bioﬁlm formation by each strain was normalized to the WT UTI89 OD570
reading, which was scaled to 100% for each independent biological replicate plate. Statistical analysis
was performed using at least three independent biological replicates for each strain, using one-way
analysis of variance (ANOVA) with multiple comparisons to WT values and Dunnett’s post hoc correction.
Immunoblot analysis. UTI89 strains, statically incubated at 37°C in LB medium for 48 h (with
subculturing after 24 h into fresh LB), were used for evaluation of type 1 pilus production. Cultures were
normalized to an OD600 of 1, and 1 ml of each normalized culture was pelleted and concentrated 10
in 1 SDS buffer containing 1 M HCl. Cell lysates were boiled for 5 min to dissociate assembled type 1
pili and immediately neutralized with 1 M NaOH. Equivalent volumes of each sample were analyzed by
SDS-PAGE. Membranes were blotted using antiserum raised against type 1 pili (FimA) (49) at a 1:5,000
dilution.
RNA extraction, DNase treatment, reverse transcription, and qPCR. Bacterial cultures were grown
as described for immunoblot analysis. Extraction of bacterial RNA was performed using the Qiagen
RNeasy kit and quantiﬁed on a NanoDrop 2000c instrument. One-microgram samples were DNase I
treated using Turbo DNase I (Ambion) and veriﬁed as devoid of DNA using PCR and a series of primers
annealing to the rrsH gene. Reverse transcription of 0.5 g of DNase-treated sample from each strain was
performed using SuperScript II reverse transcriptase (Life Technologies) according to the manufacturer’s
protocol and as described previously (33). The reverse-transcribed product was puriﬁed and quantiﬁed
using a NanoDrop 2000c instrument and used for quantitative PCR (qPCR) analysis with TaqMan
chemistry (50). Determination of relative fold changes between different strains and the wild-type control
was performed following the ΔΔCT method of Pfafﬂ (51). For these analyses, we utilized 25 ng cDNA
template. Triplicate wells per sample were used for the analysis. Standard controls were incorporated in
each analysis, including DNase I-treated RNA samples (no reverse transcriptase), and DNA (positive)
controls for each primer set and probe. The primers and probe sets used were as follows: gene of interest
(GOI), purF (probe, 5=-6FAM-CCGCTATGTTGGCCG-3=; primers, purF_F [5=-CCGCCATCGCTGCTACA-3=] and
purF-R [5=-TCATCGCCACACAGGCATA-3=]); housekeeping normalizer gene gyrB (probe, 5=VIC-ACGAACT
GCTGGCGGA-3=). Reactions were multiplexed for every experiment. qPCR analyses were performed a
total of three times, sampling 3 independent biological replicate cultures.
Bacterial adherence and internalization assays. 5637 (ATCC HTB-9) bladder epithelial cells were
seeded in 24-well plates and grown to conﬂuence in complete RPMI 1640 medium (Gibco) supplemented
with 10% fetal bovine serum (Atlanta Biologicals). Bacterial strains were grown as described for
immunoblot analysis and normalized to an OD600 of 0.5 in sterile phosphate-buffered saline (PBS). In
triplicate wells, bladder epithelial cells were infected at a multiplicity of infection (MOI) of approximately
20 bacteria per epithelial cell. To synchronize bacterial adherence, tissue culture plates were centrifuged
at 600  g for 5 min, and plates were incubated at 37°C in 5% CO2 for 2 h. To determine the number
of adherent and intracellular UPEC bacteria, one set of triplicate wells was washed 5 times with PBS to
remove nonadherent bacteria, and monolayers were lysed by the addition of 0.1% Triton X-100 and
mechanical disruption to release intracellular bacteria. Tenfold serial dilutions of cell culture lysates were
plated on LB agar for enumeration of CFU. In parallel, triplicate wells were processed for total bacterial
titers at 2 h postinfection by the addition of Triton X-100 (ﬁnal concentration, 0.1%), mechanical
disruption, and plating of 10-fold serial dilutions on LB agar. To determine the number of intracellular
UPEC bacteria, a set of triplicate wells was washed 3 times in sterile PBS, followed by the addition of fresh
RPMI containing 100 g/ml gentamicin (Gibco) to kill extracellular bacteria. After another 2 h of
incubation at 37°C in 5% CO2, wells were washed 3 times in sterile PBS to remove cellular debris and
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gentamicin, and monolayers were lysed by the addition of 0.1% Triton X-100 and mechanical disruption.
Tenfold serial dilutions of cell culture lysates were plated on solid LB agar, and intracellular bacterial titers
were determined by enumeration of CFU. Triplicate wells were processed for total bacterial titers at 4 h
postinfection by the addition of Triton X-100 (ﬁnal concentration, 0.1%) with mechanical disruption and
plating of 10-fold serial dilutions on LB agar. Bacterial adherence and internalization are expressed as a
percentage of the total bacterial titers for each independent experiment, with each assay performed a
minimum of three times.
HA assays. Bacteria were grown as described for immunoblot analysis studies. Production of type 1
pili was assessed by hemagglutination (HA) of guinea pig erythrocytes as previously described (30), using
bacterial cultures that were normalized to an OD600 of 1. Guinea pig red blood cells were obtained from
the Colorado Serum Company. In parallel, HA assays were conducted using PBS containing 4% mannose
to discriminate among type 1 pili (mannose-sensitive HA) and other adhesive ﬁbers. Data are represen-
tative of two independent biological replicate experiments with each sample assayed in duplicate.
Bacterial expulsion assay. Bacteria were grown and prepared for infection as described for BEC
adherence assays. Bacterial expulsion was determined as described previously (10). Brieﬂy, 5637 cell
monolayers were infected at an MOI of 100 in triplicate, and after 1 h, monolayers were washed with
sterile PBS to remove nonadherent bacteria. Monolayers were incubated in fresh RPMI containing 100
g/ml gentamicin for 1 h at 37°C, followed by several washes with sterile PBS. At this time point
(corresponding to 0 h), six wells infected by each strain were lysed by addition of 0.1% Triton X-100 to
determine the initial level of intracellular bacteria. To the remaining wells, RMPI medium containing 100
mM D-mannose and 25 g/ml of the bacteriostatic reagent trimethoprim (Sigma) was added to
prevent bacterial reattachment and replication. Cocultures were incubated for an additional 4 h. At
the end of the incubation, 50 l of culture supernatant was collected from each well and plated on
solid LB to determine expelled bacterial titers. The percentage of extracellular bacteria at 4 h was
calculated relative to the intracellular bacterial load at 0 h, and values were expressed as percent
bacterial ﬂuxing. Each assay was repeated 3 times, and each independent experiment contained six
replicate wells per strain.
Mouse infection studies. Seven- to 9-week-old female C3H/HeN or C3H/HeJ mice (Harlan) were
transurethrally inoculated with 107 CFU of each UTI89 strain as previously described (33). To ensure the
proper and humane treatment of animals, all animal studies were carried out in strict accordance with
the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes
of Health (52) and the Vanderbilt University Medical Center’s Institutional Animal Care and Use Com-
mittee (IACUC), who approved all protocols. Bacterial colonization was assessed by plating 10-fold serial
dilutions of whole-bladder homogenates and enumerating the recoverable CFU. Bacterial titers represent
the total luminal, adherent, and intracellular bacteria in each whole bladder. Statistical analyses were
performed using the two-tailed Mann-Whitney t test.
Whole-bladder gentamicin protection assay. At the indicated infection time points, bladders were
aseptically removed, bisected, and washed twice in sterile PBS. Washes were pooled and plated for
enumeration of CFU to determine luminal bacterial titers. Washed bladders were incubated in 100 g/ml
gentamicin for 90 min at 37°C with gentle shaking to kill adherent extracellular bacteria. Bladders were
washed in sterile PBS to remove debris and residual gentamicin and were subsequently homogenized in
sterile PBS. Serial dilutions of bladder homogenates were plated on solid LB agar to enumerate
intracellular bacterial titers.
Chloroquine resistance assays. The 5637 bladder epithelial cell line (ATCC HTB-9) was used for
chloroquine resistance assays. Cells were seeded in 24-well tissue culture dishes and grown to conﬂuence
as described for the adherence and internalization assays. UPEC cells were normalized to an OD600 of 0.5
in sterile PBS and were inoculated into six replicate wells at an MOI of 20. Tissue culture plates were
centrifuged at 600  g to synchronize bacterial adherence, and the plates were incubated at 37°C in 5%
CO2 for 2 h. Cell monolayers were washed twice with sterile PBS to remove nonadherent bacteria. For
each strain, one set of six replicate wells was incubated in RPMI containing 100 g/ml gentamicin, and
in parallel, a set of six replicate wells was treated with RPMI containing 100 g/ml gentamicin and 2.5
mg/ml chloroquine (Sigma) for 90 min at 37°C. After antibiotic treatment, cell monolayers were washed
three times in sterile PBS, and BEC monolayers were lysed by addition of 0.1% Triton X-100. Bacterial
titers were enumerated by plating 10-fold serial dilutions on LB agar. For determination of the chloro-
quine resistance of planktonically grown bacteria, UPEC strains were grown in LB with shaking at 37°C
to mid-log phase (4 h). Bacterial cultures were normalized to an OD600 of 0.3 in sterile PBS or PBS
containing 2.5 mg/ml chloroquine and were subsequently incubated at 37°C with gentle shaking for 90
min. Bacterial survival was determined by enumerating CFU (10-fold serial dilutions) on LB agar. Data are
representative of at least 2 independent biological replicate experiments.
For whole-bladder analyses, mice were infected with the indicated UPEC strain for 3 to 4 h prior to
euthanasia and aseptic removal of the bladder. Bladders were bisected and washed to determine luminal
bacterial titers as described for whole-bladder gentamicin protection assays. Washed bladders were then
incubated in sterile PBS containing 100 g/ml gentamicin and 2.5 mg/ml chloroquine for 90 min at 37°C
with gentle shaking. Gentamicin- and chloroquine-treated bladders were washed in PBS to remove
residual antibiotic and were homogenized in sterile PBS. Intracellular bacterial titers were enumerated by
plating serially diluted bladder homogenates on LB agar. For all chloroquine resistance assays, graphs
depict the geometric mean of recovered bacterial titers, and statistical analyses were performed using
the two-tailed Mann-Whitney t test.
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